August 2019 // Funding

Updated: Nov 6, 2020

Synendos receives a co-fund by the European Union as part of the SME Instrument phase 1 (Horizon2020) to contribute to the translation of our preclinical programme into clinical development.

Recent Posts

See All

October 2020 // Funding

Synendos and Prof. Jürg Gertsch received an Innosuisse Innovation Grant (total value of CHF 950’000).

© 2019 Synendos Therapeutics, Inc. All Rights Reserved.

  • LinkedIn - cerchio grigio
  • Twitter - cerchio grigio